Perspectives on Time in Range

Professor Christophe De Block and Associate Professor Julia Mader on Time in Range

Professor Christophe De Block and Associate Professor Julia Mader discuss the major benefits of using TIR in clinical practice.

Professor Christophe De Block and Associate Professor Julia Mader discuss the implications of guidelines for CGM and TIR use 

About Professor Christophe De Block

Professor Christophe De Block is head of the Department of Endocrinology, Diabetology and Metabolism at the University of Antwerp, Belgium. His latest research has focused on the application of continuous glucose monitoring, functional insulin therapy and sensor-augmented pump therapy.

About Associate Professor Julia Mader

Dr. Julia Mader is Associate Professor of Medicine at the Division of Endocrinology and Diabetology at the Medical University of Graz, Austria and deputy head of the Diabetes Outpatient Clinic. She has published more than 100 peer-reviewed scientific papers focused on diabetes technology.


Dr. Alice Cheng on Time in Range

Dr. Alice Cheng explains why Time in Range as a clinical metric is a strong complement to the already established HbA1c

About Dr. Alice Cheng

Dr. Alice Cheng is an endocrinologist at Trillium Health Partners in Mississauga and St. Michael’s Hospital in Toronto and an Associate Professor in the Department of Medicine at the University of Toronto. For her contributions to diabetes care, she has received a Certificate of Recognition from the Ontario College of Family Physicians.


Dr. Richard Bergenstal on Time in Range

Dr. Richard Bergenstal explains how CGM data and the Ambulatory Glucose Profile (AGP) Report can be interpreted and used in a clinical setting.

About Dr. Richard Bergenstal

Dr. Richard Bergenstal is an endocrinologist and Executive Director of the International Diabetes Center in Minneapolis, Minnesota, United States. Two areas of recent focus include standardising glucose data reports utilising the AGP and effective strategies for implementing CGM and hybrid closed-loop therapy into clinical practice.